Almost everyone did not notice that the cumulative market value of the three CRISPR listed companies tripled between June 2017 and June 2018, with a cumulative market value of nearly $6 billion. However, in the past six months, the market value of these three companies has fallen by nearly… Continue Reading Progress of the latest clinical trials of 3 CRISPR listed companies

  On November 26, He Jiankui, a scientist at Southern University of Science and Technology, announced that a pair of genetically edited babies named Lulu and Nana were born in China in November. The genes of the twins have been modified to make them naturally resistant to AIDS after birth.… Continue Reading Chinese scientists claim that the world’s first genetic editing baby is born! Naturally resistant to AIDS

  Gump’s troubles In 2013, Gump’s actor, the second American movie star Tom Hanks, who won the Oscar for Best Actor Award for two consecutive years, frankly told the hosts and viewers on a nighttime talk show: “When I went to see a doctor, he said to me, ‘Do you… Continue Reading From lizard venom to a new drug for type 2 diabetes – Lyxumia

  On November 23, the application for the Bayer prostate cancer new drug Xofigo (Rainium Chloride [223Ra] Injection) was officially accepted by CDE. Xofigo was first approved by the FDA on May 15, 2013 for the treatment of advanced bone metastases in castration-resistant prostate cancer. In the Phase 3 ALSYMPCA… Continue Reading Bayer prostate cancer new drug Xofigo applied for listing in China

  Recently, Sage Therapeutics issued a statement saying that the FDA has extended the PDUFA date for priority review of new drug applications for its new drug Zulress (brexanolone) for the treatment of postpartum depression. This means that the previously disclosed PDUFA on December 19, 2018 will be extended by… Continue Reading FDA delays approval of new postpartum depression drug brexanolone, requiring risk assessment and mitigation strategies

  On November 21, Taiwan’s OBI Pharma announced that the FDA has granted OBI-888 the right to treat orphan drugs for pancreatic cancer. OBI-888 is a first-in-class passive immunotherapy treatment of monoclonal antibody against Globo H, a tumor cell surface antigen, whose mechanism of action is antibody-dependent cytotoxicity, antibody-dependent macrophage… Continue Reading Taiwan’s Hao Ding Harvest FDA’s third orphan drug qualification: OBI-888 for the treatment of pancreatic cancer

  1. Why medication is necessary? Both domestic and imported aspirin can cause fatal stomach bleeding and cerebral hemorrhage. Hundreds of millions of patients are taking small doses of aspirin, which must be administered and should be standardized. Aspirin medication (paper or verbal): Enteric tablets should be taken before meals;… Continue Reading 15 FAQ for low-dose aspirin

  Last year, the rumor that Pascal Soriot had to change to the CEO of Teva was very rampant, and the reasons for his departure were constant. Pascal Soriot himself declined to comment directly on the matter and later sent an internal memo to the staff, urging them to continue… Continue Reading Rumors: AstraZeneca will replace the CEO? Successor candidates may be generated internally

  Fatty liver has become the most common chronic liver disease in the world. The prevalence of fatty liver in adults in China has exceeded 25%, and one in every 3 adults in Beijing and Shanghai has fatty liver. When B-ultrasound diagnoses fatty liver, do you need medication? What medicine… Continue Reading What drugs can be used for fatty liver?

  The patient, male, 36 years old, developed sore throat after a cold, fever in a local hospital, diagnosed with upper respiratory tract infection, and received levofloxacin. After intravenous infusion of 0.2 g of levofloxacin, there was chills, chills, low back pain, yellow staining of the skin sclera, and then… Continue Reading Avoid these drugs when you have Favism